QQQ   293.01 (-0.11%)
AAPL   144.79 (+0.58%)
MSFT   247.90 (-0.04%)
META   149.75 (+1.66%)
GOOGL   98.73 (+1.24%)
AMZN   100.76 (+1.55%)
TSLA   165.85 (+3.48%)
NVDA   198.91 (+0.45%)
NIO   12.36 (+1.56%)
BABA   118.80 (-1.47%)
AMD   74.96 (-0.27%)
T   19.92 (-0.40%)
MU   63.22 (+0.67%)
F   12.99 (+0.54%)
CGC   2.83 (+2.54%)
GE   82.28 (+1.40%)
DIS   109.97 (+0.25%)
AMC   5.26 (-0.38%)
PFE   44.18 (-0.16%)
PYPL   81.09 (+0.35%)
NFLX   364.49 (-0.10%)
QQQ   293.01 (-0.11%)
AAPL   144.79 (+0.58%)
MSFT   247.90 (-0.04%)
META   149.75 (+1.66%)
GOOGL   98.73 (+1.24%)
AMZN   100.76 (+1.55%)
TSLA   165.85 (+3.48%)
NVDA   198.91 (+0.45%)
NIO   12.36 (+1.56%)
BABA   118.80 (-1.47%)
AMD   74.96 (-0.27%)
T   19.92 (-0.40%)
MU   63.22 (+0.67%)
F   12.99 (+0.54%)
CGC   2.83 (+2.54%)
GE   82.28 (+1.40%)
DIS   109.97 (+0.25%)
AMC   5.26 (-0.38%)
PFE   44.18 (-0.16%)
PYPL   81.09 (+0.35%)
NFLX   364.49 (-0.10%)
QQQ   293.01 (-0.11%)
AAPL   144.79 (+0.58%)
MSFT   247.90 (-0.04%)
META   149.75 (+1.66%)
GOOGL   98.73 (+1.24%)
AMZN   100.76 (+1.55%)
TSLA   165.85 (+3.48%)
NVDA   198.91 (+0.45%)
NIO   12.36 (+1.56%)
BABA   118.80 (-1.47%)
AMD   74.96 (-0.27%)
T   19.92 (-0.40%)
MU   63.22 (+0.67%)
F   12.99 (+0.54%)
CGC   2.83 (+2.54%)
GE   82.28 (+1.40%)
DIS   109.97 (+0.25%)
AMC   5.26 (-0.38%)
PFE   44.18 (-0.16%)
PYPL   81.09 (+0.35%)
NFLX   364.49 (-0.10%)
QQQ   293.01 (-0.11%)
AAPL   144.79 (+0.58%)
MSFT   247.90 (-0.04%)
META   149.75 (+1.66%)
GOOGL   98.73 (+1.24%)
AMZN   100.76 (+1.55%)
TSLA   165.85 (+3.48%)
NVDA   198.91 (+0.45%)
NIO   12.36 (+1.56%)
BABA   118.80 (-1.47%)
AMD   74.96 (-0.27%)
T   19.92 (-0.40%)
MU   63.22 (+0.67%)
F   12.99 (+0.54%)
CGC   2.83 (+2.54%)
GE   82.28 (+1.40%)
DIS   109.97 (+0.25%)
AMC   5.26 (-0.38%)
PFE   44.18 (-0.16%)
PYPL   81.09 (+0.35%)
NFLX   364.49 (-0.10%)
NASDAQ:REVBW

Revelation Biosciences - REVBW Short Interest Ratio & Short Volume

$0.03
+0.01 (+26.38%)
(As of 01/27/2023 08:34 AM ET)
Add
Compare
Today's Range
$0.03
$0.03
50-Day Range
$0.01
$0.04
52-Week Range
$0.01
$0.38
Volume
3,997 shs
Average Volume
60,566 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Revelation Biosciences Short Interest Data

Current Short Volume
13,000 shares
Previous Short Volume
13,000 shares
Change Vs. Previous Month
No Change
Dollar Volume Sold Short
$546.00
Short Interest Ratio / Days to Cover
0.1
Last Record Date
September 30, 2022
Today's Trading Volume
3,997 shares
Average Trading Volume
60,566 shares
Today's Volume Vs. Average
-93.40%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Revelation Biosciences ?

Sign up to receive the latest short interest report for Revelation Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

REVBW Short Interest Over Time

REVBW Days to Cover Over Time

REVBW Percentage of Float Shorted Over Time


Revelation Biosciences (NASDAQ:REVBW) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/30/202213,000 shares $546.00 No ChangeN/A0.1 $0.04
9/15/202213,000 shares $804.70 +4.8%N/A0.1 $0.06
8/31/202212,400 shares $629.92 No ChangeN/A0.1 $0.05













REVBW Short Interest - Frequently Asked Questions

What is Revelation Biosciences' current short interest?

Short interest is the volume of Revelation Biosciences shares that have been sold short but have not yet been covered or closed out. As of September 30th, traders have sold 13,000 shares of REVBW short. Learn More on Revelation Biosciences' current short interest.

How does Revelation Biosciences' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Revelation Biosciences: Check-Cap Ltd. (25.93%), CollPlant Biotechnologies Ltd. (0.38%), G Medical Innovations Holdings Ltd (0.33%), and Global Cord Blood Co. (2.79%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.27 billion), Charter Communications, Inc. ($2.66 billion), TC Energy Co. ($2.53 billion), Chesapeake Energy Co. ($1.86 billion), Coinbase Global, Inc. ($1.83 billion), Lucid Group, Inc. ($1.78 billion), T. Rowe Price Group, Inc. ($1.77 billion), Rivian Automotive, Inc. ($1.69 billion), Zoom Video Communications, Inc. ($1.35 billion), and Williams-Sonoma, Inc. ($1.35 billion). View all of the most shorted stocks.

What does it mean to sell short Revelation Biosciences stock?

Short selling REVBW is an investing strategy that aims to generate trading profit from Revelation Biosciences as its price is falling. REVBW shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Revelation Biosciences?

A short squeeze for Revelation Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of REVBW, which in turn drives the price of the stock up even further.

How often is Revelation Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including REVBW, twice per month. The most recent reporting period available is September, 30 2022.



This page (NASDAQ:REVBW) was last updated on 1/27/2023 by MarketBeat.com Staff